EDITORIAL
Role of Dronedarone in Atrial Fibrillation: More Questions Than Answers
Daniel E. Hilleman, Pharm.D., FCCP, and Aryan N. Mooss, M.D.
ORIGINAL RESEARCH ARTICLES
Atenolol Exposure and Risk for Development of Adverse Metabolic Effects: A Pilot Study
Hrishikesh A. Navare, M.S., Reginald F. Frye, Pharm.D., Ph.D., Rhonda M. Cooper-DeHoff, Pharm.D., M.S., Jonathan J. Shuster, Ph.D., Karen Hall, M.D., Siegfried O. F. Schmidt, M.D., Ph.D., Stephen T. Turner, M.D., and Julie A. Johnson, Pharm.D.
Synergistic Effect of Statins and Postmenopausal Hormone Therapy in the Prevention of Skeletal Fractures in Elderly Women
Ludmila N. Bakhireva, M.D., Ph.D., M.P.H., Michael R. Shainline, M.S., M.B.A., Shelley Carter, R.N., M.P.H., Scott Robinson, M.A., M.P.H., Sarah J. Beaton, Ph.D., James J. Nawarskas, Pharm.D., and Margaret J. Gunter, Ph.D.
Drug Adsorption Efficacy and Palatability of a Novel Charcoal Cookie Formulation
Wendy Klein-Schwartz, Pharm.D., M.P.H., Suzanne Doyon, M.D., FACMT, and Thomas Dowling, Pharm.D., Ph.D., FCP
Analysis of Linezolid-Associated Hematologic Toxicities in a Large Veterans Affairs Medical Center
Quentin Minson, Pharm.D., and Chris A. Gentry, Pharm.D.
REVIEWS OF THERAPEUTICS
Dronedarone: A New Antiarrhythmic Agent
Ola O. Oyetayo, Pharm.D., Carrie E. Rogers, Pharm.D., and Prudence O. Hofmann, Pharm.D.
Treatment Options for Multiple Sclerosis: Current and Emerging Therapies
Kristen M. Gawronski, Pharm.D., Michelle M. Rainka, Pharm.D., Malti J. Patel, M.D., and Francis M. Gengo, Pharm.D., FCP
Pharmacologic Treatment for Postpartum Depression: A Systematic Review
Rosalyn C. Ng, Pharm.D., Cheryl K. Hirata, Pharm.D., Winnie Yeung, Pharm.D., Ellen Haller, M.D., and Patrick R. Finley, Pharm.D.
Adjunctive Use of Atypical Antipsychotics for Treatment-Resistant Generalized Anxiety Disorder
Raymond A. Lorenz, Pharm.D., Cherry W. Jackson, Pharm.D., FASHP, and Marianne Saitz, D.O., M.P.H.
CASE REPORTS
Bivalirudin Use During Radiofrequency Catheter Ablation Procedures in Two Patients with a History of Heparin-Induced Thrombocytopenia
Brooke E. Baetz, Pharm.D., Edward P. Gerstenfeld, M.S., M.D., Daniel M. Kolansky, M.D., and Sarah A. Spinler, Pharm.D., FCCP, FAHA
Meropenem-Induced Vanishing Bile Duct Syndrome
Annabel L. Schumaker, Pharm.D., and Jason F. Okulicz, M.D.
Falsely Elevated Tacrolimus Levels Caused by Immunoassay Interference Secondary to b-Galactosidase Antibodies in an Infected Liver Transplant Recipient
John P. Knorr, Pharm.D., Kevin S. Grewal, M.D., Manjula Balasubramanian, M.D., Nancy Young, M.D., Radi Zaki, M.D., Kamrin Khanmoradi, M.D., Victor Araya, M.D., and Jorge Ortiz, M.D.
PRN OPINION PAPER
Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
Krystal L. Edwards, Pharm.D., Daniel M. Riche, Pharm.D., Jeffrey S. Stroup, Pharm.D., Jennifer D. Goldman-Levine, Pharm.D., Rosalyn S. Padiyara, Pharm.D., L. Brian Cross, Pharm.D., and Michael P. Kane, Pharm.D., FCCP
ACCP COMMENTARY
The Essential Research Curriculum for Doctor of Pharmacy Degree Programs
American College of Clinical Pharmacy
Mary W. Lee, Pharm.D., Patrick G. Clay, Pharm.D., W. Klugh Kennedy, Pharm.D., Mary Jayne Kennedy, Pharm.D., Nicole M. Sifontis, Pharm.D., Dana Simonson, Pharm.D., Kevin M. Sowinski, Pharm.D., William J. Taylor, Pharm.D., Robyn M. Teply, Pharm.D., Orly Vardeny, Pharm.D., and Timothy E. Welty, Pharm.D.